Construction of SPA7074-deficient mutant of biocontrol strain Streptomyces pactum Act12 and characterization of its secondary metabolites
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    [Objective] To disrupt spa7074, which encodes a member of the TetR family transcriptional factors, in biocontrol strain Act12 and characterize the secondary metabolites in the mutant strain. [Methods] We disrupted the gene spa7074 by homologous recombination. The secondary metabolites of the mutant strain Δspa7074 and Act12 were detected by HPLC. The structure was analyzed by MS and NMR. [Results] Compared to the wild-type strain, the production of some unknown compounds in the mutant strain Δspa7074 increased obviously. We purified one of the compounds and identified as oligomycin D by MS and NMR analysis. [Conclusion] An oligomycin D-producing strain Δspa7074 was derived via genetic engineering.

    Reference
    Related
    Cited by
Get Citation

Xuemei Duan, Feiyang Zhao, Xia Yan, Quanhong Xue, Xiaoxia Li, Bingjie Wen, Lianghui Jia, Hua Yan. Construction of SPA7074-deficient mutant of biocontrol strain Streptomyces pactum Act12 and characterization of its secondary metabolites. [J]. Acta Microbiologica Sinica, 2016, 56(12): 1883-1891

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 31,2016
  • Revised:May 13,2016
  • Adopted:
  • Online: November 29,2016
  • Published:
Article QR Code